Extendicare (TSE:EXE) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Extendicare reported a 64.9% increase in adjusted EBITDA for Q3 2024, driven by growth in long-term care and home health care services. The company also announced the full redemption of its 2025 debentures and progress on its redevelopment projects, including a new 256-bed LTC home in St. Catharines.
For further insights into TSE:EXE stock, check out TipRanks’ Stock Analysis page.
